Nrf2 inhibits macrophage inflammatory responses by blocking pro-inflammatory factor transcription (34), and estradiol inhibits CRC by modulating the Nrf2-related pathway (35) Estrogen further inhibits CRC in the absence of Nrf2 by upregulating ERβ-related alternative pathways (36). Here, ESR2 is linked to colorectal carcinoma.